Skip to main content

Table 1 Literature review of adult Burkitt lymphoma with obstructive symptoms

From: Recurrent small bowel obstruction caused by Burkitt lymphoma in an elderly man: a case report and review of the literature

Author Age (yr) Sex BL type Presentation Abdominal syndrome Syndrome recurrence Treatment regimen Outcome
Fernandes et al. [20] 21 Female Sporadic Abdominal pain Intussusception Yes Resection alone NR
Simson et al. [21] 22 Female Sporadic Persistent abdominal pain, appendicitis Appendicitis then intussusception No Resection with adjuvant chemotherapy NR
Sharma et al. [22] 26 Male HIV Viral syndrome, abdominal distention Obstruction No Resection then R-CODOX-M/IVAC NR
Wetter et al. [23] 29 Female HIV Abdominal pain Intussusception No Resection NR
Gupta et al. [24] 33 Female HIV Loose stool, abdominal discomfort, nausea, obstructive jaundice Obstructive jaundice No CODOX-M/IVAC Complete remission
Felix et al. [25] 34 Male NR Abdominal pain Intussusception Yes Resection NR
Özant et al. [26] 37 Female Sporadic Abdominal pain, nausea, vomiting Obstruction due to intussusception No Resection with hyperCVAD Complete remission
Mizutani et al. [27] 38 Male NR Abdominal pain Obstruction No Cyclophosphamide and doxorubicin with R-CODOX-M/IVAC Complete remission
Zerwas et al. [28] 52 Male NR Abdominal pain, nausea, vomiting Intussusception NR Resection NR
Kasparian et al. [this report] 78 Male Sporadic Abdominal pain, nausea, vomiting Obstruction Yes Resection then DA-EPOCHR Complete remission
  1. This is the first reported case of BL presenting with recurrent SBO in the geriatric population
  2. Abbreviations: DA-EPOCHR Dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, hydroxydaunorubicin, and rituximab, HIV Human immunodeficiency virus, hyperCVAD Cyclophosphamide, vincristine, doxorubicin, NR Not reported, (R) CODOX-M /IVAC (Rituximab) cyclophosphamide, vincristine, doxorubicin, and high-dose methotrexate, with intrathecal methotrexate, alternating with ifosfamide, etoposide, and cytarabine-A